Briacell Therapeutics Corp has split its stock 5 times since its initial public offering (IPO). The first stock split occurred on December 03, 2014 with the ratio of 4-for-13, meaning that for 13 shares of BCTX owned pre-split, shareholders then owned 4 shares. 4 more splits have been implemented since then. The most recent stock split took place on August 26, 2025 on a 1-for-10 basis.
These splits have increased BCTX stock's liquidity and made it more appealing to a larger group of investors. However, it's important to remember that these actions only change the number of shares and the price per share with no impact on Briacell Therapeutics Corp's total market capitalization.
For more detailed information of Briacell Therapeutics Corp's stock splits, view the table below:
The answer will depend on the decisions of the company's managers and market volatility. Briacell Therapeutics Corp has not made an official announcement regarding whether it will enact a stock split or reverse stock split, but it has a history of doing so when BCTX stock prices become too high or too low for retail investors. Therefore, the ultimate decisions will certainly be made by Briacell Therapeutics Corp's board of directors. Typically, no action is taken until its price per share reaches a specific threshold.
